Patients see first savings from Biden's drug price push, as pharma lines up its lawyers
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010.
Feb 19, 2024
0
1
